期刊文献+

哮喘患儿持续吸入激素治疗对骨代谢指标和骨密度影响 被引量:3

Effects of continuous inhaled corticosteroid of biochemical indexes of bone metabolism and bone mineral density in children with asthma
下载PDF
导出
摘要 目的 观察持续小剂量吸入糖皮质激素对哮喘患儿骨代谢指标和骨密度的影响。方法 随机将 4 5例 5~ 8岁哮喘缓解期患儿分 3个开放治疗组 ,吸入糖皮质激素 (布地奈德 )分别为 10 0、2 0 0、30 0 μg/d ,持续 12个月。于治疗开始 ,6、12个月行临床评估和肺功能FEV1测定 ;检测血骨钙素 (OST)、胰岛素样生长因子 1(IGF 1)、骨碱性磷酸酶 (BALP)和尿脱氧吡啶 (DPD) /尿肌酐 (Cr)水平。用双能X线骨密度仪监测骨密度 (BMD)。结果 哮喘患儿治疗后临床评分和肺功能FEV1明显改善 ;血OST稍高于正常儿童对照组 ,但无显著差异 ;血BALP显著高于正常对照组 ;血IGF 1水平与同龄正常儿童比较显著增高 ;尿DPD/Cr水平显著低于正常对照组 ;治疗前后患儿股骨近端 (股骨颈 ,大转子 ,Ward′s三角 )、脊柱区域 (2~ 4 )和前臂 (前臂远端和近侧端 )的BMD无显著降低。结论 持续小剂量吸入糖皮质激素对哮喘患儿的骨代谢指标和BMD无明显抑制影响。 Objective To observe the influence of long-term treatment with inhaled corticosteroid on biochemical bone indexes and bone mineral density (BMD) in children with asthma. Methods The design was a randomized, paralleled group study with 3 low dose regiments of 100, 200,300 micrograms of budesonide per day in 45 children with asthma aged 5-8 years old for 12 months. Before inhaled corticosteroid therapy and 6th,12th month,clinical effects were observed and lung function(FEV1) was measured; concentration of serum osteocalcin(OST),insulin-like growth factor-1(IGF-1),bony alkaline phosphatase (BALP) and urinary deoxypyridinolin: creatinine (DPD/Cr) were measured; BMD was examined by dual energy X-ray absorptiometry. Results Clinical evaluation was improved and there was significant increase in FEV1 of asthmatic children. The amount of serum OST was slightly higher,yet no significant compared with that of normal control group. There was significant increase of serum BALP in asthmatic children after treatment; there was significant increase in serum IGF-1 of patients group after treatment compared with in normal children at the same age group; there was significant decrease in urinary DPD/Cr after treatment.There was no significant decrease in BMD before and after treatment at the hip (neck of femur , trochanter of femur ,Ward′s triangle),the lumber area of the spine (L2-4) and forearm (ultradis, distal). Conclusion Long-term treatment with low does corticosteroid dose not restrictedly affect bone metabolism and BMD in children with asthma.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2004年第6期447-449,共3页 Journal of Applied Clinical Pediatrics
基金 广西壮族自治区科技厅回国基金资助 (科桂回 992 0 0 1 9)
关键词 哮喘 儿童 吸入治疗 糖皮质激素 骨代谢 骨密度 asthma children inhaled treatment corticosteroid bone metabolism bone mineral density
  • 相关文献

参考文献6

  • 1何颜霞,刘建华.有关哮喘持续状态治疗的相关问题[J].实用儿科临床杂志,2003,18(10):774-776. 被引量:8
  • 2刘衍秋,陈宝海,王云风,张恒兴,杨进,龙腾,吴晓放,腾树春.强的松对正常大白鼠骨代谢的影响[J].实用儿科临床杂志,1998,13(3):161-162. 被引量:3
  • 3儿童哮喘防治常规(试行)[J].中华儿科杂志,1998,36(12):747-751. 被引量:2372
  • 4Chay OM,Goh A,Lim WH,et al.Effects of inhaled corticosteroid on bone turnover in children with bronchial asthma[J].Respirology,1999,4(1):63-67.
  • 5Jean AL,Clifford JR,Marjolein V,et al.Association between insulin-like growth factor-1 and bone mineral density in older women and men:the Framingham heart study[J].J Clin Endocrinol Metab,1998,83 (12):4257-4262.
  • 6Nicola AH,Kenneth RC,Steven K,et al.Adverse effects of inhaled corticosteroids[J].Am J Med,1995,98 (2):196-208.

二级参考文献11

  • 1张纪芸,刘道祯,杨剑辉,赵玉堂,李金花.肾病综合征患儿骨矿物质含量[J].实用儿科临床杂志,1994,9(3):141-142. 被引量:4
  • 2金玉,赵季琳,薛延.肾病综合征患儿骨代谢研究[J].中国实用儿科杂志,1997,12(1):21-22. 被引量:3
  • 3Biarent D. Therapeutic strategies in near fatal asthma in children[J]. Pediatr Pulmonol, 2001, (23 Suppl) :S'90-$93.
  • 4Wemer HA. Status asthmaticus in children[ J ]. Chest, 2001,119(6) : 1913 - 1929.
  • 5Stephanopoulos DE, Monge R, Schell KH, et al. Continuotrs intravenous terbutaline for pediatric status asthmaticus[J ]. Crit Care Med, 1998,26(10) : 1744-- 1748.
  • 6Ream RS, Loftis LL, Albem GM, et al. Efficacy of IV theophylline in children with sever status asthmaticus [J ]. Chest,2001,119(5) : 1480-1488.
  • 7Kudukis TM, Manthous CA, Schmidt GA, et al. Inhaled heliumoxygen revisited: effect of inhaled helium-oxygen during the treatment of status asthmaticus in children [J ]. J Pediatr, 1997, 130(2) :217-224.
  • 8Nakagawa TA, Johnston SJ, Falkos SA, et al. Life-threatening status asthmaticus treated with inhaled nitric oxide[J]. J Pediatr,2000,137( 1 ) : 119--220.
  • 9陈重义.肾病综合征的内分泌功能紊乱[J]国外医学(儿科学分册),1987(04).
  • 10黄元庆,孔慧.容许性高碳酸血症通气治疗危重哮喘20例分析[J].中国全科医学,2002,5(5):396-397. 被引量:1

共引文献2377

同被引文献17

  • 1左瑞平,曹丽,冷弢,袁桂芬,刘艳丽.长期服用肾上腺皮质激素对儿童生长激素分泌的影响[J].实用儿科临床杂志,2004,19(8):648-649. 被引量:6
  • 2顾之燕,董震.变应性鼻炎的诊治原则和推荐方案(2004年,兰州)[J].中华耳鼻咽喉头颈外科杂志,2005,40(3):166-167. 被引量:1709
  • 3林荣军,潘玉娟,孙秀芳.长期吸入糖皮质激素对支气管哮喘儿童血清生长激素与身高的影响[J].实用儿科临床杂志,2006,21(14):935-935. 被引量:17
  • 4Sharek PJ, Bergman DA. The effect of inhaled steroidson the lineargrowth of children with asthma : AMeta-anal-ysis[J]. Pediatrics, 2000.106(1) : 8.
  • 5Pedersen S. Clinical safety of inhaled corticosteroids forasthma in chil-dren:an update of long-term trials[J]. DrugSaf, 2006, 29(7): 599-612.
  • 6BisgaardH, Allen D, Milanowski J, et al. Twelve-monthsafety and effi-cacy of inhaled fluticasone propionate inchildren aged 1 to 3 yearswithrecurrentwheezing[J], Pedi-atrics, 2004,113(2) : 87-94.
  • 7Global Initiative for Asthma. Global Strategy for Asthma Diagnosis and Prevention[J].Global Initiative for Asthma, 2009.[EB/OL].
  • 8Lesnnrai R, Watson L, Webb NJA. Nephrotic syndrome in childienf J].Paediatr and Child Health,2010,20( 1) :3642.
  • 9Sinha A,Bagga A. Nephrotic syndrome[J]. Indian J Pediatr,2012,79(8):1045-1055.
  • 10Emould S, Godron A, Nelson JR, et al. Idiopathic nephritic syn-drome in children : Incidence, clinical presentation,and outcome inthe county of Gironde,France [J]. Arch Pediatr, 2011,18(5):522-528.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部